Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

LocumTenens.com Expands Mental Health Services with Psychology Staffing


LocumTenens.com, a leading physician and advanced practitioner staffing agency, announced today it is expanding its behavioral health services through the launch of psychology staffing. This addition complements the psychiatry staffing services the company has been offering for the past 25 years.

“The United States is currently facing a mental health crisis that has been exacerbated by the COVID-19 pandemic,” said Chris Franklin, president of LocumTenens.com. “Mental healthcare clinicians, particularly those residing in rural areas or places where there are limited resources for patients, are overwhelmed. Vulnerable populations don’t have access to the care they desperately need. Our psychology staffing services will help significantly increase access to behavioral health care.”

According to a recent LocumTenens.com survey, 73% of psychologist respondents indicated they are expecting to see more mental health issues arise in patients post-COVID-19. Additionally, 52% of clinicians across all specialties reported experiencing increased stress, burnout or mental health issues due to COVID-19, underscoring the importance of mental healthcare for clinicians as well.

Anna Shaw Children’s Institute is already experiencing the benefits of its partnership with LocumTenens.com.

“We are thrilled with our Locum Tenens psychologist, and our families and patients are able to receive much-needed assessments and counseling,” said Terri Woodruff, executive director of the Children’s Institute. Because of the way the pandemic has disrupted their routines, children are an especially vulnerable population and may need additional resources and support during this time.

LocumTenens.com also announced that part of its psychology expansion will include telepsychology services via secure video conference connection. The company’s survey of clinicians revealed 74% of respondents’ organizations increased their telehealth service offerings due to COVID-19.

“For 25 years, we’ve helped facilitate psychiatrists providing life-saving care to patients all across the country,” said Kevin Thill, executive vice president of LocumTenens.com. “The expansion of psychology staffing services will no doubt complement and enhance the care our psychiatrists have been providing, and I’m excited to see the impact these psychologists have moving forward, both on patients and other clinicians who can benefit from mental healthcare.”

About LocumTenens.com

LocumTenens.com specializes in the temporary placement of physicians, CRNAs, physician assistants and nurse practitioners at healthcare facilities across the U.S. As the industry’s most-visited job board, LocumTenens.com helps healthcare organizations connect with the professionals they need to ensure patients have access to quality care. Founded in 1995, LocumTenens.com is a clear leader in the healthcare staffing industry, helping place clinicians who deliver care to more than seven million patients in over 2,400 healthcare facilities in the U.S. LocumTenens.com is a Jackson Healthcare® company.

Learn more at http://www.locumtenens.com/about.

For LocumTenens.com media inquiries, please contact Meaghan Johnston at mjohnston@locumtenens.com.

Share article on social media or email:

Americans are Blindsided by Medical Bills During COVID-19


Most Americans do not know the prices of their healthcare prior to receiving the care. This can lead to unforeseen medical bills that can be financially devastating to Americans and their families. Recently, Cynthia A Fisher, Founder of PatrientRightsAdvocate.org partnered with YourUpdateTV to discuss the importance of healthcare price transparency.

A video accompanying this announcement is available at: https://youtu.be/l0EX546XbLs

Systemwide healthcare price transparency can become law by passing the Healthcare Price Transparency Act, which requires hospitals and insurance companies to reveal their discounted, cash prices and secret, negotiated rates, as part of the next COVID-19 stimulus package.

This is a bi-partisan issue. 90% of all Americans surveyed want to know prices and be able to shop for the best quality at the lowest price – driving down the costs of care and coverage.

Businesses contracting directly with price transparent providers for care and coverage, are already saving 30-50% for their employees and their families. Economists estimate that this bi-partisan measure will save over $1 trillion per year for the United States.

Healthcare price transparency is the key to lowering America’s devastatingly high healthcare costs through informed, empowered consumers.

For more information, please visit PatientRightsAdvocate.org

About Cynthia A. Fisher:

Cynthia A. Fisher is a life sciences entrepreneur, independent investor, and corporate board director. She founded WaterRev, LLC to invest in novel technologies that enable sustainable practices in water use. She serves on the public company boards of The Boston Beer Company (SAM) and Easterly Government Properties, Inc. (DEA). Cynthia is best known for her pioneering work as Founder and CEO of ViaCord, Inc., a leading umbilical cord blood stem cell banking service which she started in 1993. In 2000, she co-founded and was President of the cellular medicines company, ViaCell, Inc. (Previously to founding ViaCord, Cynthia ran the Blood Bank Division of Haemonetics Corporation, a medical equipment manufacturer. She began her career in sales at IBM focusing on healthcare IT, insurance, and defense industries. Cynthia holds an MBA from Harvard Business School, as well as an Honorary Doctorate of Science and BS in Biophysics from Ursinus College.

About YourUpdateTV:

YourUpdateTV is a social media video portal for organizations to share their content. It includes separate channels for Health and Wellness, Lifestyle, Media and Entertainment, Money and Finance, Social Responsibility, Sports and Technology.

Share article on social media or email:

Skin Tags, You’re It! Along with the Other ‘Safe’ Skin Growths That Rub Us the Wrong Way


Jennifer Wong, RPA-C

From the discomfort of corns and calluses to the disruptive appearance of keratosis pilaris bumps, seborrheic keratosis growths and skin tags, there are a number of non-threatening skin conditions that can pop up.

“We all want to stay alert for skin cancer,” notes Jennifer Wong, a certified registered physician’s assistant specializing in dermatology with Advanced Dermatology PC. “But it’s important to acknowledge that other ‘safe’ skin conditions can cause real quality-of-life-issues. And they can be treated to improve people’s day-to-day.”

From the discomfort of corns and calluses to the disruptive appearance of keratosis pilaris bumps, seborrheic keratosis growths and skin tags, there are a number of non-threatening skin conditions that can pop up.

“These conditions are common,” notes Wong. “About half of us will develop skin tags – medical name acrochordons. Their prevalence means that dermatologists have developed a range of treatments – some do-it-yourself, some in the office.”

The benign skin growths people contend with have different causes – some lifestyle, others still being researched.

“Corns and calluses,” Wong explains, “are directly connected to the wear and tear we subject our skin to: these extra layers of skin build up as protection: in the case of corns, due to pressure against our skin onto the bone underneath; in the case of calluses, due repeated friction from regular activities, like gripping tools or playing an instrument.”

Other benign skin growths do not have a direct lifestyle origin.

“Skin tags are typically small, dangling ovals of skin,” describes Wong. “They may be related to genes, hormones, or underlying conditions. The same is true for keratosis pilaris: small bumps that usually show up on the upper arms and thighs due to pores becoming plugged with the skin protein keratin. Seborrheic keratoses, which are warty- or waxy-looking tan or brown growths, generally develop as people age; genes and the sun may be factors.”

“Fortunately,” continues Wong, “we do know how to treat these conditions so that they don’t interfere with people’s lives.”

With that in mind, she offers the following suggestions.

5 Tips to Take the Bother Out of Benign Skin Growths:

1. Rule out more serious problems: “It’s really important to make sure that the problem is benign,” emphasizes Wong. “For example, we want to make sure that it’s seborrheic keratosis and not skin cancer – or a wart, which is due to a contagious virus. It’s important for everyone to develop a skin check-up schedule that will establish their baseline skin condition and support ongoing monitoring for problems, especially skin cancer.”

2. Relieve the pressure: “With corns and calluses,” says Wong, “lifestyle adjustments are the solution. Protective padding – for example moleskin for a callus, adhesive pads for corns – can alleviate the friction and pressure. For both, a warm-water soak and gentle use of a pumice stone can remove the thickened skin. And then, for corns, it’s time to re-evaluate our footwear choices: we need comfortable shoes that will not exert pressure. Fortunately, there are lots of stylish and gentle options available today.”

3. Remember: maintenance matters: “Regular moisturizing is important for the gradual resolution of corns and calluses,” advises Wong. “Moisturizing is also important to address keratosis pilaris. And to get rid of the bumps, exfoliation is key. Chemical exfoliants like glycolic acid, lactic acid, or salicylic acid can be effective. But if the condition is stubborn, an office visit for laser treatments or microdermabrasion can clear the way. After treatment, moisturizing and exfoliating need to be a regular routine.”

4. Growths interfering with life? Get rid of them: “If skin tags or seborrheic keratoses are obvious or interfere with clothing or jewelry,” Wong suggests, “they can be removed. Your dermatologist has a range of options, including freezing (cryosurgery) or electrosurgery. Skin tags can also be removed by scissor excision.”

5. Excessive? Changing? Painful? See a doctor: “If a ‘benign’ skin growth changes or becomes painful, it needs evaluation to rule out a medical problem,” states Wong. “And with skin tags, if there are a great number, that requires a checkup for underlying health problems, in particular diabetes.”

“’Harmless’ skin growths can still be problems,” concludes Wong. “Your dermatologist can help solve them.”

Bio: Jennifer Wong, RPA-C is a certified registered physician’s assistant specializing in dermatology with Advanced Dermatology PC

Advanced Dermatology P.C. and the Center for Laser and Cosmetic Surgery (New York & New Jersey) is one of the leading dermatology centers in the nation, offering highly experienced physicians in the fields of cosmetic and laser dermatology as well as plastic surgery and state-of-the-art medical technologies. http://www.advanceddermatologypc.com.

Share article on social media or email:

The Conference Forum Launches the 1st Dedicated Newsletter to Patients as Partners in Clinical Research


“The newsletter highlights the voices of patients, industry and advocacy working to ensure exceptional, safe patient experiences in clinical trials” – Kate Woda, Director, Patients as Partners conference

The Conference Forum is pleased to announce the launch of the Patients as Partners newsletter. This is the first publication dedicated to highlighting the voices that are putting patients at the center of clinical research and making sure patient involvement gets implemented into the medicines development cycle.

The Patients as Partners newsletter builds on the success of the company’s Patients as Partners conference, the first conference in the US guided by patients with Pharma R&D executives and FDA to demonstrate how patient involvement gets implemented throughout the medicines development cycle in order to drive greater efficiencies in getting therapeutics to patients faster.

“The newsletter highlights the voices of patients, industry and advocacy working to ensure exceptional, safe patient experiences in clinical trials,” said Kate Woda, Director, Patients as Partners conference.

The newsletter will cover a wide range of topics from demonstrating how patient involvement gets done, patient input into the design of clinical trials. patient engagement, reducing the burden to find and participate in clinical research for both patients and physicians, and regulatory POVs.

The inaugural issue features interviews from:

Christeen Moburg, Head of Patient Advocacy, Sangamo Therapeutics, tangibly including patient engagement throughout the medicine development cycle;

Chip Bell, PhD, Customer Loyalty Speaker, customer service lessons from outside the industry on how to treat patients like partners even through a pandemic;

Fernando Albertorio, PhD, Advocate for the visually impaired and Hermansky-Pudlak Syndrome communities, and co-founder of Sunu, Inc, discusses advocacy and innovation for Hermansky-Pudlak Syndrome and the visually impaired;

Neena Nizar, EdD, Founder and President of the Jansen’s Foundation, highlights the path to creating a foundation for Jansen’s Metaphyseal Chondrodysplasia and the path of advocacy for other rare diseases;

Tina Aswani Omprakash, writer, patient advocate for the chronically ill and clinical trial participant, talks about the benefits of empowering patients participating in clinical trials.

The issue also includes a write-up of the Patients as Partners advisory meeting, which focused on the challenges the COVID-19 pandemic has created, as well as the opportunities for patient empowerment. The advisory meeting included representation from biopharma and patient advocacy.

In addition to the newsletter, the Conference Forum also produces related podcast series. “With the conferences, podcasts and quarterly newsletter, we aim to provide comprehensive support for patient advocates, R&D executives, the FDA, technologists and service companies dedicated to patient inclusivity and a collaborative approach to medicine development,” said Valerie Bowling, Executive Director at the Conference Forum.

About the Conference Forum:

The Conference Forum is a life science industry research firm that develops conferences primarily around how to get therapeutics to patients faster. They examine and challenge the complex ecosystem of drug development and delivery, bringing ideas together from a variety of sources to help advance clinical research with common goals that are patient-focused.

The Conference Forum presents strategic level conferences, both public and private, as well as developing focus groups and advisory boards for professionals in the life science and healthcare industries. They currently offer conferences for pharma/biotech professionals including R&D leaders, CEOs, business development/licensing, medical affairs/safety, chief patient officers/advocates, clinical innovation champions, investors and drug delivery specialists. The company also publishes six newsletters, reports and produces podcasts.

Learn more about The Conference Forum at theconferenceforum.org.

Share article on social media or email:

Atlanta Counseling Center Opens to Meet Mental Health Needs During COVID-19 Pandemic


Thriveworks Counseling in Atlanta (Buckhead) offers teletherapy options via telephone and video. Individuals will be able to choose the option that best suits their needs during these unprecedented times.

In the near future, Thriveworks Atlanta (Buckhead) counselors will be settling into the physical location, located at 2999 Piedmont Road, Suite 100, Atlanta, GA 30305. This location’s team of counselors are highly trained and experienced with helping clients across a broad spectrum of mental health concerns.

Alongside the ease and accessibility of online counseling, Thriveworks offers its clients additional competitive benefits such as innovative technologies and quick scheduling. In addition, flexible appointment options are offered, which include evening and weekend sessions in addition to their normal daytime availability.

Ryan Culkin, Executive Clinic Director at Thriveworks, understands the importance of offering clients quick and easy assistance: “At Thriveworks we believe that the therapeutic journey can be difficult and painful, this is why it is our mission to make it as seamless as possible to get you connected with an excellent therapist fast.”

About Thriveworks:

Thriveworks Counseling believes the cornerstone for compassionate care is centered around putting the client and their needs first. The mental health professionals at Thriveworks can provide a broad range of services, including but not limited to depression therapy, anxiety therapy, trauma therapy, couples therapy, family therapy, stress management, and more.

The Thriveworks team strives for excellence. That’s why they pride themselves on helping people live full and happy lives. To learn more about Thriveworks Atlanta (Buckhead), call (678) 804-7374 or visit https://thriveworks.com/atlanta-therapy/.

Share article on social media or email:

Williamson Medical Center, Ascension Saint Thomas West, and Maury Regional Health have the best value outcomes for Heart Failure in Columbia, TN


best value outcomes for Heart Failure in Columbia, TN

“Dexur’s value analysis tracks a patient’s episode of care from the date of admission for 90 days and includes the index hospitalization, rehospitalization, home health, nursing home, and ED costs.”

Dexur’s analysis of medicare claims of hospitals within a 50-mile radius of Columbia, TN, showed that Williamson Medical Center, Ascension Saint Thomas West, and Maury Regional Health had the best value outcomes over a 90 day episode for Heart Failure. Dexur’s value analysis tracks a patient’s episode of care from the date of admission for 90 days and includes the index hospitalizations, rehospitalization, home health, nursing home, and ED costs. Total cost of care data helps patients make appropriate choices and helps local ACOs, such as Maury Regional Health Network, LLC, make appropriate referral choices. The analysis was risk-adjusted, for alive and non-hospice patients and was done at the DRG level, specifically DRG 291: Heart Failure and Shock with Major Complication or Comorbidity (MCC), to adjust for complications and comorbidities.

Williamson Medical Center’s total cost of care over a 90 day episode was $21,443 (for the period between July 2016 and June 2019). The index hospitalization cost was $7,988 and the average rehospitalization cost per hospitalization was $7,291. The cost per rehospitalization was at an average of $16,371. Meanwhile, the average ED costs per hospitalization (when ED is involved) was $638.

Ascension Saint Thomas West’s total cost of care over a 90 day episode was $22,443 (for the period between July 2016 and June 2019). The index hospitalization cost was $8,547 and the average rehospitalization cost per hospitalization was $8,451. The cost per rehospitalization was at an average of $18,693. Meanwhile, the average ED costs per hospitalization (when ED is involved) was $976.

Maury Regional Health’s total cost of care over a 90 day episode was $22,514 (for the period between July 2016 and June 2019). The index hospitalization cost was $8,150 and the average rehospitalization cost per hospitalization was $8,623. The cost per rehospitalization was at an average of $19,952. Meanwhile, the average ED costs per hospitalization (when ED is involved) was $1,043.

Share article on social media or email:

Swift Medical launches integrated digital wound care solution with Homecare Homebase


As a company tackling the real-world challenges of nurses on the frontlines, this partnership with Swift Medical helps our customers provide the most compassionate care possible

Homecare Homebase℠ (HCHB), the nation’s #1 software for home health and hospice, is partnering with global digital wound care leader Swift Medical to provide high-quality, cost efficient care through an integrated solution. Wound care patients are often the most complex, high risk population in home health. As such, wound care represents a significant opportunity for home health and hospice providers to use technology to drive quality improvement, increase patient understanding of their healing progress and dramatically reduce operational expenses. Swift Medical’s digital wound management solution helps home health providers deliver standardized care in the most collaborative, empathetic and efficient manner. Now Swift Medical’s solution will be integrated with HCHB software, allowing for a simpler adoption process and more effective user experience for home health and hospice providers.

This partnership comes at a time when care is increasingly being delivered at home. For patients with wounds in particular, this can create challenges, as wound care is a highly specialized discipline with a shortage of certified wound specialists. “More than ever before, patients want to heal at home,” says Carlo Perez, Founder and CEO of Swift Medical. “Our solution helps augment the wound care proficiency of every clinician and enables scarce wound experts to remotely manage care for a broader population of patients, driving profound organizational efficiencies.”

“As a company tackling the real-world challenges of nurses on the frontlines, this partnership with Swift Medical helps our customers provide the most compassionate care possible,” says Scott Pattillo, Chief Strategy Officer at Homecare Homebase. “By empowering clinicians to provide high quality wound care, we enable patients to live more independently and stay healthier at home.”

About Swift Medical

Swift Medical is the global leader in digital wound care. Its innovative technology is used by over 3,500 healthcare organizations across the continuum of care to enhance the prevention, assessment, treatment and ongoing management of wounds. In home health, Swift Medical has delivered proven improvements to agencies’ bottom lines while simultaneously enhancing quality of care and patient outcomes. For more information, visit swiftmedical.com.

About Homecare Homebase, LLC

Homecare Homebase (HCHB) is a Dallas-based software leader offering hosted, cloud- based solutions to streamline operations, simplify compliance and boost clinical and financial outcomes for homecare and hospice agencies. Our customized mobile solutions enable real-time, wireless data exchange and communication between field clinicians, physicians and office staff for better care, more accurate reporting and faster payment. Founded by industry veterans in 1999, the company is now part of the Hearst Health Network. For more information visit hchb.com or call us toll-free at 1-866-535- HCHB (4242).

About Hearst Health

The mission of Hearst Health is to help guide the most important care moments by delivering vital information into the hands of everyone who touches a person’s health journey. Each year in the U.S., care guidance from Hearst Health reaches 85 percent of discharged patients, 205 million insured individuals, 103 million home health visits and 3.2 billion dispensed prescriptions. The Hearst Health network includes FDB (First Databank), Zynx Health, MCG, Homecare Homebase and MHK (formerly MedHOK). Hearst also holds a minority interest in the precision medicine and oncology analytics company M2Gen. Follow Hearst Health on Twitter @HearstHealth and LinkedIn @Hearst-Health.

Share article on social media or email:

ASHA Applauds CDC for Updated Mask Recommendations That Include Adaptations for People With Hearing Loss, Other Communication Disorders


The American Speech-Language-Hearing Association (ASHA) applauds the U.S. Centers for Disease Control and Prevention (CDC) for issuing newly updated COVID-19 mask considerations that include adaptations and alternatives for people with hearing loss and other communication disorders.

In a June 8 letter to CDC Director Robert Redfield, ASHA asked the agency to emphasize the need for clear face masks and use of other communication aids to protect people with hearing loss and other communication disorders. ASHA noted that this was a pressing public health issue, given the large segment of the U.S. population that has a communication disorder. Solid face masks and coverings reduce the effectiveness of spoken communication in numerous ways, including dampening and filtering sound, degrading speech intelligibility, and removing visual cues.

In written correspondence to ASHA informing the association of its revised recommendations, Redfield stated, “We appreciate ASHA raising this important issue, and CDC recognizes the unique challenges that individuals with communication disorders encounter when wearing solid face coverings or when interacting with essential workers, such as health care providers, who communicate through solid face coverings.” He further acknowledged the critical work being done by ASHA members at this time.

“We greatly appreciate the CDC’s updated recommendations,” said Theresa H. Rodgers, MA, CCC-SLP, ASHA 2020 President. “They allow for modifications that can improve communication success for everyone—including those with communication disorders. It bears noting that breakdowns in communication can be far more than a nuisance. They can result in real harm, particularly in medical settings where it’s imperative that communication between patients and healthcare providers is clear.”

In its updated, “Considerations for Wearing Cloth Face Coverings,” the CDC states: “Adaptations and alternatives should be considered whenever possible to increase the feasibility of wearing a cloth face covering or to reduce the risk of COVID-19 spreading if it is not possible to wear one.”

The health agency cites specific populations in its revised recommendations, including those with hearing loss: “People who are deaf or hard of hearing—or those who care for or interact with a person who is hearing impaired—may be unable to wear cloth face coverings if they rely on lipreading to communicate,” the CDC states. “In this situation, consider using a clear face covering. If a clear face covering isn’t available, consider whether you can use written communication, use closed captioning, or decrease background noise to make communication possible while wearing a cloth face covering that blocks your lips.”

In its June letter, ASHA stated that clear face masks and other flexible communication methods—such as shared computer screens, notepads, whiteboards, voice-to-speech applications, personal sound amplifiers, use of plexiglass barriers, and other related resources—can assist in making communication more effective, most critically for imparting one’s medical needs and preferences.

“In this challenging environment, ASHA remains committed to continued advocacy to realize its vision of making effective communication, a human right, accessible and achievable for all. We are very pleased to work with CDC to make progress on this front, and we look forward to our continued engagement with the agency,” said Rodgers.

For more information, visit http://www.asha.org.

About the American Speech-Language-Hearing Association (ASHA)

ASHA is the national professional, scientific, and credentialing association for 211,000 members and affiliates who are audiologists; speech-language pathologists; speech, language, and hearing scientists; audiology and speech-language pathology support personnel; and students. Audiologists specialize in preventing and assessing hearing and balance disorders as well as providing audiologic treatment, including hearing aids. Speech-language pathologists identify, assess, and treat speech and language problems, including swallowing disorders. http://www.asha.org

###

Share article on social media or email:

COVID-19, Recession Deal Double Whammy to Property & Casualty Insurance BPS Industry—Everest Group


Everest Group

The P&C insurance BPS market is expected to transition through significant operating model and engagement structure changes.

The COVID-19 pandemic has dealt a blow to the Property & Casualty (P&C) insurance industry, and the current recession is exacerbating the impact, according to Everest Group. Consequently, Everest Group is revising down its projected growth rates for the P&C insurance business process services (BPS) market. Everest Group estimates the P&C insurance BPS industry, currently measured at US$2.4 billion, will attain only low single digit growth rather than the double-digit growth previously expected, putting a question mark on the market’s ability to cross US$3 billion by 2022.

The P&C insurance BPS growth rate in 2018-2019 (approximately 10%) was already the lowest it had been in the past four years, due to the strong linkage of the market to economic cycles and the recessionary prospects that had begun to surface. Then came the COVID-19 pandemic, which has negatively impacted both the personal and commercial lines of the P&C insurance industry, and a fully recognized recession with poor recovery prospects for the near future.

The P&C insurance BPS industry is expected to bear a four-fold impact from the pandemic:

  • Operations: Business operations will be disrupted mainly due to reduced mobility and difficulties of working from remote environments. For example, IT infrastructure is strained, and physical inspection of claims is more challenging.
  • Costs: Costs will depend on how reduction in claims, drastic measures of liquidity preservation, and increasing litigations against insurers play out. For example, auto claims will likely fall due to reduced driving, but lawsuits for not covering business interruption losses caused by the shutdowns will add to insurers’ costs.
  • Customer demand: Customer demand will vary across different product segments, ranging from high to extremely strained demands, making the demand landscape diverse in terms of the impact. Customer demands may include specific product lines such as cybersecurity and directors and officers (D&O) insurance. Customers also will likely demand more value for their money, increasing the chances of switching based only on premium prices.
  • Compliance: A host of compliance and regulatory measures will have to be introduced to protect all the affected stakeholders amidst the evolutionary landscape. For instance, pressure to extend coverage for cybersecurity attacks and business interruption losses will increase.

“With the extreme shifts in business environment due to COVID-19, both for insurers as well as their service partners, many have struggled for even basic operational continuity,” said Skand Bhargava, practice director at Everest Group. “While the industry has now largely adjusted to the vagaries of the changed operating environment, these changes appear to be more permanent than expected. The P&C insurance BPS market is expected to transition through significant operating model and engagement structure changes. Now, with the onset of a recession, it is even more imperative for service providers to understand the developments in insurers’ sourcing strategies and the implications on future sourcing requirements.”

In particular, Everest Group recommends that providers tap into these emerging trends:

  • Localized delivery with greater onshore/nearshore mix
  • Talent upskilling to move up the value chain
  • Expanding first-time buyer engagements
  • Transformation consulting to enable buyers to adapt their operation models to the new demand environment
  • Adding more digital point solutions to the outsourcing levers mix.

These findings are discussed in detail in Everest Group’s new report, “Property & Casualty (P&C) Insurance BPS State of the Market Report 2020: Deconstructing the Present and Expected Future of Sourcing Strategies.” In this report Everest Group offers a detailed analysis of third-party outsourcing of business process services in the P&C insurance industry, including market size and growth, adoption trends, present and expected sourcing strategies, and action items for service providers.

***Download the complimentary report abstract.***

***Also, visit Everest Group’s COVID-19 page for a Global Service Delivery tracker, recent reports, webinars, and more.***

About Everest Group

Everest Group is a consulting and research firm focused on strategic IT, business services, engineering services, and sourcing. Our clients include leading global enterprises, service providers, and investors. Through our research-informed insights and deep experience, we guide clients in their journeys to achieve heightened operational and financial performance, accelerated value delivery, and high-impact business outcomes. Details and in-depth content are available at http://www.everestgrp.com/.

###

Share article on social media or email:

Genedata Automates Biopharma R&D with Seamless Integration of Lab Equipment


News Image

By bringing together Thermo Fisher’s automation systems and the Genedata Biopharma platform, all molecule, sample, assay, and analytics data across both instruments and processes are fully integrated, giving researchers the power to make data-based decisions and uncover insights not possible before.

Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced a collaboration with Thermo Fisher Scientific, a leading international pharmaceutical and laboratory equipment supplier, to integrate the two platforms to provide seamless automation of biopharma R&D operations. The combined platform directly imports raw instrument data from Thermo Fisher Scientific instruments into the Genedata platform, where the data can be processed and interpreted with all other data collected along the entire biopharma R&D workflow. The centralized platform makes it possible for scientists to integrate and digitalize automation systems for sample handling, lab operations, and testing, and digitally trace all results for every sample to make data-driven decisions that expedite R&D breakthroughs.

“Our collaboration with Genedata will enable biopharma companies to fully integrate R&D automation platforms for the direct capture, processing, and analysis of the large amount of data being produced by today’s high-throughput robotic systems. Scientists can now do more experiments in a shorter time and maximize their lab automation investments,” said Hansjoerg Haas, Senior Director, Lab Automation, Thermo Fisher Scientific. “By bringing together Thermo Fisher’s automation systems and the Genedata Biopharma platform, all molecule, sample, assay, and analytics data across both instruments and processes are fully integrated, enabling traceability for molecules, samples, results, and processes. This gives researchers the power to make data-based decisions and uncover insights not possible before.”

Thermo Fisher and Genedata are implementing standard integration interfaces to easily set up and operate Thermo Fisher’s lab equipment and robotics with the Genedata Biopharma platform, which acts as a workflow backbone connecting all information from early discovery to development. The newly integrated platform supports complex sub-workflows such as cherry picking, plasmid construction, antibody expression and expansion, and plasmid and antibody purification, and drives significant efficiency gains along the full biopharma R&D workflow. The integration includes both Thermo Fisher laboratory instruments and Thermo Fisher Momentum software.

“We are pleased to welcome Thermo Fisher as our latest lab automation Ready-to-Run™ partner,” said Othmar Pfannes, Ph.D., CEO of Genedata. “Biopharmaceutical and biotech companies already automate complex laboratory workflows using our seamless integration with lab equipment from many major instrument providers. Our customers expect data traceability across the entire biopharma R&D workflow and by further automating integration of lab instrument data, we are providing a central and structured database for every experimental sample, result, and process. This supports the growing demand for data-driven drug discovery.”

About Genedata

Genedata transforms data into intelligence with innovative software solutions and domain-specific consulting services that automate complex, large-scale experimental processes and enable organizations to maximize the ROI in their R&D, spanning early discovery all the way to the clinic. Founded in 1997, Genedata is headquartered in Switzerland with additional offices in Germany, Japan, Singapore, the UK, and the US.

http://www.genedata.com

LinkedIn | Twitter | YouTube

Contact

Miles Fisher-Pollard

Genedata

Public Relations

Phone: +41 61 511 85 61

pr@genedata.com

Disclaimer

The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company’s products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

All product and service names mentioned are the trademarks of their respective companies.

Share article on social media or email: